Introduction
One of the most important goals of pharmacological research is the search for new molecular structures which exhibit effective antitumour activities [1] [2] . This has driven inorganic and organometallic chemists to look for new metal compounds with good activities, preferably against tumours that are responsible for high cancer mortality. Organotin(IV) compounds are a widely studied class of metal-based antitumour drugs and their intensive investigation has led to the discovery of compounds with excellent in vitro antitumour activity, but, in many cases, disappointingly low in vivo potency or high in vivo toxicity [3] [4] [5] . It is well established that organotin(IV) compounds are very important in cancer chemotherapy because of their apoptotic inducing character [6, 7] . The design of improved organotin(IV) antitumour agents occupies a significant place in cancer chemotherapy, as revealed from their remarkable therapeutic potential reflected in recent research reports [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] .
The binding ability of organotin(IV) compounds towards DNA depends on the coordination number and nature of the groups bonded to the central tin atom. The phosphate group of DNA sugar backbones usually acts as an anchoring site and the nitrogen of DNA base binding is extremely effective, this often resulting in the stabilization of the tin center as an octahedral species. Low doses of organotins can exhibit anti-tumoural activity [20] [21] [22] [23] [24] [25] and have suggested an action mode via a gene-mediated pathway in the cancer cells, opening a new research sub-area on organotin(IV) compounds. The chemical and biochemical aspect of DNA inhibition, including biotechnological aspects of organotin(IV) cancer chemotherapy, has also been described [26] .
Organotin(IV) halides and their complexes with amines and other ligands exhibit borderline activities in vivo against P388 and L1210 leukaemia. The in vivo prescreenings against these two cancers used initially by the National Cancer Institute (NCI), USA, were later replaced by in vitro pre-screenings against a panel of human tumour cell lines, viz., MCF-7 and EVSA-T ( mammary cancers), WIDR (colon cancer), IGROV (ovarian cancer), M19 MEL (melanoma), A498 (renal cancer) and H226 (non-small-cell lung cancer) [27] .
When organotin(IV) halides are dissolved in water, the pH of the solution decreases dramatically because they are converted slowly into organotin(IV) hydroxides and then to bis(triorganotin)oxides or diorganotin oxides. In contrast, di-and tri-organotin(IV) carboxylates do not suffer from this disadvantage and generally remain intact in water for long periods; i.e. days. Consequently, a large number of organotin(IV) carboxylates have been investigated for their antitumour potential. Among organotin(IV) carboxylates, triorganotin(IV) carboxylates are quite well known as bactericides and fungicides [28, 29] and subsequently several such derivatives were found to be potent when screened for their cytotoxicity [30] [31] [32] . Exceptionally high in vitro antitumour activities were also reported for triphenyltin(IV) benzoates and salicylates against a human mammary tumour (MCF-7) and a colon carcinoma (WIDR) and found to be comparable with that of mitomycin C [33] . Several attempts were also made to synthesize triphenyltin (IV) carboxylates by modifying the carboxylate moiety with biologically active carboxylate moieties and also by incorporating lipophilic/hydrophilic properties in them, since the lipophilic properties are essential for crossing the cell membrane and their hydrophilic character for being accepted by the water-rich cell [27] . The promising development in the search for antitumour organotin(IV) compounds has been achieved with some triphenyltin(IV) carboxylates, such as 3,6-dioxaheptanoate and 3,6,9-trioxadecanoate [34] , 4-carboxybenzo-15-crown-5 and 4-carboxybenzo-18-crown-6 [34, 35] , steroidcarboxylate [36] and terebate [27, 32, 37] when screened in vitro against human tumour cell lines, as per the NCI protocol.
In view of the increasing interest in organotin(IV) carboxylates and prompted by their structural diversity [38] and broad therapeutic activity [27] , organotin(IV) complexes of Schiff bases derived from amino acids have also been investigated extensively [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] . An overview of the coordination behaviour of such Schiff bases towards organotin(IV) is shown in Scheme 1. Some of these organotin(IV) compounds were screened for antitumour activity in vivo in Ehrlich ascites carcinoma cells [41] and cytotoxic activity in vitro against cell lines of human origin [47, 49] . The in vitro cytotoxicity results demonstrated that triphenyltin(IV) compounds derived from 2-
onates are more active than CDDP (cisplatin) [49] . Interestingly, all three triphenyltin(IV) compounds show comparable cytotoxic activity across a panel of cell lines and this prompted us to investigate related systems by modifying the amino acetate part of the molecule, which might improve dissolution properties and thereby influence cytotoxicity. Within this paper, we present a series of new organotin(IV) carboxylates involving the 2-{[(2Z)-(3-hydroxy-1-methyl-2-butenylidene)]amino}-4-methyl-pentanoate and 2-{[(E)-1-(2-hydroxyphenyl)-alkylidene]amino}-4-methyl-pentanoate skeletons (Scheme 2, compounds 1-4), their synthesis, spectroscopic characterization, crystal structures and preliminary cytotoxic studies.
Experimental

Materials
Ph 3 SnCl (Fluka AG), Ph 2 SnCl 2 , 2′-hydroxyacetophenone (Aldrich), l-leucine (Himedia), 2-hydroxybenzaldehyde and acetylacetone (Sisco) were used without further purification. The solvents used in the reactions were of AR grade and were dried using standard procedures.
Physical measurements
Carbon, hydrogen and nitrogen analyses were performed with a Perkin Elmer 2400 series II instrument. IR spectra in the range 4,000-400 cm −1 were obtained on a Perkin Elmer Spectrum BX series FT-IR spectrophotometer with samples 
VII VIII a
(R = CH 3 or C 6 H 5 , R' = CH 2 , X = CH 3 or H; R = C 6 H 5 , R' = CHCH 2 C 6 H 5 , X = CH 3 or H) 13 C-and 119 Sn-NMR spectra were recorded on a Bruker AMX 400 spectrometer and measured at 400.13, 100.62 and 149.18 MHz. The 1 H, 13 C and 119 Sn chemical shifts were referred to Me 4 Si set at 0.00 ppm, CDCl 3 set at 77.0 ppm and Me 4 Sn set at 0.00 ppm, respectively.
X-ray crystallography
Crystals of compounds 1 and 3 suitable for an X-ray crystalstructure determination were obtained from toluene/hexane (v/v 1:1) and ethanol, respectively, by slow evaporation of the solutions of the respective compounds. All measurements were made on a Nonius KappaCCD diffractometer [50] with graphite-monochromated Mo Kα radiation (λ= 0.71073 Å) and an Oxford Cryosystems Cryostream 700 cooler. Data reduction was performed with HKL Denzo and Scalepack [51] . The intensities were corrected for Lorentz and polarization effects, and empirical absorption corrections based on the multi-scan method [52] were applied. Equivalent reflections, other than Friedel pairs, were merged. The data collection and refinement parameters are given in Table 1 , and views of the molecules are shown in Figs. 1 and 2 . The structure of 1 was solved by direct methods using SIR92 [53] . Heavy-atom Patterson methods [54] were employed for 3, which revealed the position of the Sn-atom, and the remaining non-hydrogen atoms in 3 were located in a Fourier expansion of the Patterson solution, which was performed by DIRDIF94 [55] .
Both triphenyltin(IV) compounds exist as polymeric chains with the carboxylate ligands bridging between the Sn-atoms and in each case the asymmetric unit contains just one of the chemical repeat units of the polymer. One of the phenyl ligands in 1 and 3 and the iso-propyl group in 1 are disordered over two orientations. Two sets of overlapping positions were defined for the atoms of the disordered groups and the site occupation factors of the major conformations of these groups refined to 0.578(9), 0.552 (8) (4) is included for the convenience of discussion and 0.70(1), respectively. Similarity restraints were applied to the chemically equivalent bond lengths and angles involving all disordered C-atoms, while neighbouring atoms within and between each conformation of the disordered groups were restrained to have similar atomic displacement parameters.
The imine H-atom in 1 was placed in the position indicated by a difference electron density map and its position was allowed to refine together with an isotropic displacement parameter. All remaining H-atoms were placed in geometrically calculated positions and refined by using a riding model where each H-atom was assigned a fixed isotropic displacement parameter with a value equal to 1.2U eq of its parent C-atom (1.5U eq for the methyl groups). The refinement of each structure was carried out on F 2 by using full-matrix least-squares procedures, which minimized the function
Corrections for secondary extinction were applied. Two reflections in 3, whose intensities were considered to be extreme outliers, were omitted from the final refinement. Refinement of the absolute structure parameter [56] for 1 and 3 yielded the values of −0.02(2) and −0.05(3), respectively, which confidently confirm that the refined coordinates represent the true enantiomorph. All calculations were performed using the SHELXL97 program [57] . Several crystals of 2 were tried, but all seem to exhibit diffuse scattering. Although the overall structure could be discerned and is very similar to that of 3, the R-factors remained very high, the refinement is unstable because of pseudosymmetry, and there is some unresolvable disorder at the chiral centre of the l-leucine ligand. For these reasons, the details of this structure are not reported here. Visual inspection of the crystals showed that they tended to grow in layered blocks. An individual layer could be isolated by careful cutting, but this did not yield improved data. It is possible that twinning has occurred, although twin analysis software did not reveal any twin laws and reconstructed precession images were also reasonably clean. Data collection at various temperatures did not improve the results.
Synthesis
Synthesis of the potassium salts
A typical procedure is described below.
was prepared by slow addition of a methanol solution (2 ml) of KOH (0.19 g, 3.38 mmol) to l-leucine (0.44 g, 3.35 mmol) in 10 ml methanol with continuous stirring. A methanolic solution (15 ml) of acetylacetone (0.33 g, 3.29 mmol) was added drop-wise. A pale yellow colour developed almost immediately and stirring was continued for 1 h, followed by 5 h refluxing. The volatiles were removed carefully; the pale yellow mass was stirred with diethylether and filtered. The residue was dissolved in the minimum amount of anhydrous methanol and filtered. The filtrate was precipitated with diethylether which afforded the crude product. Repeated precipitations from a methanol-diethylether mixture yielded pure L 1 HK, which was then dried in vacuo (0.68 g, 81% yield). M. 
The other potassium salts (Scheme 2), viz., An identical method to that used for the preparation of 1 was followed using Ph 3 SnCl and L 2 HK. Yellow crystals of Fig. 1 88 (s, 2H, H-10), 1.58 (s, 1H, H-11 
Experimental protocol and cytotoxicity tests
The experiment was started on day 0. On day 0, 10,000 cells per well were seeded into 96-wells flat-bottomed micro-titer plates (falcon 3072, DB). The plates were preincubated overnight at 37°C, 5% CO 2 to allow the cells to adhere to the bottom. On day 1, a three-fold dilution sequence of ten steps was made in full medium, starting with the 250,000 ng/ml stock solution. Every dilution was used in quadruplicate by adding 200 μl to a column of four wells. This procedure results in the highest concentration of 625,000 ng/ml being present in column 12. Column 2 was used for the blank. After incubation of 3 days, the plates were washed with PBS twice. Fluorescein diacetate (FDA) stock solution was diluted to 2 μg/ml with PBS and 200 μl of this solution was added to each of the control, experimental and blank wells. The plates were incubated for 30 min at 37°C and the fluorescence generated from each well was measured at an excitation wavelength of 485 nm and an emission wavelength of 535 nm using an automated microplate reader (Labsystems Multiskan MS). The data were used for construction of concentration-response curves and determination of the ID 50 values by use of Deltasoft 3 software.
The variability of the in vitro cytotocicity test depends on the cell lines used and the serum applied. With the same batch of cell lines and the same batch of serum the interexperimental CV (coefficient of variation) is 1-11% depending on the cell line and the intra-experimental CV is 2-4%. These values may be higher with other batches of cell lines and/or serum. H] n (4) was prepared by reacting the appropriate potassium salt with Ph 2 SnCl 2 in benzene in the presence of Et 3 N as a proton abstractor, a method similar to that reported earlier [59] . The synthesis of these compounds is shown in Scheme 2. The compounds are shiny colourless to yellow solids. They are stable in air and soluble in all common organic solvents.
Results and discussion
Synthesis and spectroscopy
The IR spectra displayed a strong sharp band at around 1,650 cm −1 for triphenyltin(IV) complexes (1-3) and at around 1,685 cm −1 for diphenyltin(IV) complex (4) which has been assigned to the carboxylate antisymmetric [ν asym (OCO)] stretching vibration, in accord with our earlier reports [39, 42, 43, 47, 49] . The assignment of the symmetric [ν sym (OCO)] stretching vibration band could not be made owing to the complex pattern of the spectra. The 1 H-and 13 C-NMR signals were assigned by the use of homonuclear correlated spectroscopy (COSY), heteronuclear single-quantum correlation (HSQC), heteronuclear multiple-bond connectivities (HMBC) and distortionless enhancement by polarization transfer (DEPT) experiments. The 1 H and 13 C chemical shift assignment (see Experimental) of the phenyltin moiety is straightforward from the multiplicity patterns, resonance intensities and also by comparing their n J( 13 C-119/117 Sn) values. The 1 H-NMR integration values were completely consistent with the formulation of the products. The 13 C-NMR spectra of the ligand and Sn-Ph skeletons displayed the expected carbon signals in triphenyltin(IV) complexes 1-3. The diphenyltin(IV) complex (4) deserves specific mention. The spin-spin coupling of 57 Hz between the azomethine proton and the tin nucleus, 3 J( 119/117 SnN=C 1 H) has been detected. Such coupling has previously been reported for the complexes where tin nuclei are located in a transposition to the azomethine proton [60] , confirming the presence of nitrogen-tin coordination. In addition, complex 4 (Ph 2 Sn(2-OC 6 H 4 C(H)=NCHCH 2 CH(CH 3 ) 2 COO) displayed two sets of 1 H and 13 C NMR signals from the Sn-Ph groups (see experimental) since the italicised proton in the complex is enantiotropic and causes the phenyl groups bound to the tin, and the i Bu group to be diastereotopic [61] , and thereby the two phenyl groups (Sn-Ph 2 ) experience different environments on the NMR time scale. These observations were noted earlier for diorganotin(IV) complexes of 2-{[(E)-1-(2-oxyphenyl) alkylidene]amino}phenylpropionate [49] . The triphenyltin(IV) complexes (1-3) in CDCl 3 exhibit a single sharp 119 Sn resonance in the range −83 to −103 ppm, suggesting that the Sn-atoms in the complexes have the same fourcoordinate environment [42, 47, 49, 62, 63] . This is also reflected in 1 J( 13 C-119/117 Sn) coupling constants (see experimental) and the values are unambiguously characteristic for four-coordinate tin atoms [63] . These results demonstrate that the polymeric structure with five-coordinate tin atoms found in the solid state is lost upon dissolution (see below for the crystal structure discussion). On the other hand, the X-ray crystal structure of complex 4 demonstrated a pseudo-trigonal bipyramid geometry around the tin atom [58] . The chemical shift data for this complex in CDCl 3 displayed a 119 Sn chemical shift at -340 ppm, which closely matches the shifts reported for diphenyltin (IV) amino acetate [39, 41] , which has five-coordinate Snatoms in solution. This shift testifies that the solid state structure of 4, revealed in the crystal structure, is retained in solution.
Crystal structures
The crystal structures of compounds 1 and 3 reveal that the Sn-coordination complex in each case has the basic type X polymeric chain structural motif described in Scheme 1. A preliminary investigation of the crystal structure of 2 revealed the same motif, but this structure is not described in any further detail here (see the "Experimental" for details). Views of the molecular structures of complexes 1 and 3 are shown in Figs. 1 and 2 (refer to Scheme 2 for line diagrams), while selected geometric parameters are collected in Table 2 .
The following specific details are given for the structure of 1, but the comments apply equally well to the structures of 2 and 3. It is apparent that varying the organic moiety in the Schiff base ligands has an insignificant influence on the overall structure and the coordination geometry of the Snatoms. Complex 1 has a polymeric chain structure in which a single carboxylate ligand bridges adjacent Sn-centres via its carboxylate and oxide O-atoms. The asymmetric unit contains one of the chemical repeat units of the polymeric Sn-compound. Compounds 1 and 3 in the crystal are enantiomerically pure and the absolute configuration of the molecules has been determined independently by the diffraction experiments. The stereogenic centre at C(2) of the molecules 1 and 3 has the S-configuration expected of l-leucine.
The primary coordination sphere of the Sn-atom is trigonal bipyramidal with the phenyl ligands in the equatorial plane and the axial positions occupied by one O-atom from the carboxylate group of one carboxylate ligand and the oxide O-atom of the next carboxylate ligand in the chain. This yields a trans-R 3 SnO 2 geometry. The second O-atom of the carboxylate group is not involved in the primary coordination sphere of the Sn-atom, but lies 3.386 (3) 1-(2-hydroxyphenyl) ethylidene]amino}-phenylpropionate [49] . Among all of these structures, the greatest variation in the coordination geometry is in the Sn-O(oxide) bond length, which ranges from 2.242 (2) Å in 3 to 2.539(2) Å in 2-{[(E)-1-(2-hydroxyphenyl) methylidene]amino}phenylpropionate [49] . The formal hydroxy group in the carboxylate ligand of 1 and 3 has lost its H-atom, so is negatively charged. Instead the imine N-atom is protonated, thus leading to a zwitterionic ligand. This N + -H group forms a strong intramolecular hydrogen bond with the oxide O atom (Table 3) . One of the phenyl ligands and the iso-propyl group in 1 are disordered over two orientations while one of the phenyl ligands is disordered over two almost equally occupied orientations in 3.
The polymeric structures of the triphenyltin(IV) complexes 1-3 is not repeated in the crystal structure of diphenyltin(IV) complex 4, which was described by Wang et al. [58] . In 4, a mononuclear discrete molecule, the arrangement of the donor set about the Sn-atom is distorted trigonal bipyramidal with one carboxylate and the oxide oxygen atoms from the tridentate carboxylate ligand occupying the axial positions, while the imine nitrogen atom from the carboxylate ligand and two phenyl groups are in equatorial positions (refer to Scheme 2).
Cytotoxicity studies
The in vitro cytotoxicity test of organotin(IV) compounds 1-4 was performed using the SRB test for the estimation of cell viability. The cell lines WIDR, M19 MEL, A498, IGROV and H226 belong to the currently used anticancer screening panel of the NCI, USA [64] . The MCF7 cell line is estrogen receptor (ER)+/ progesterone receptor (PgR)+ and the cell line EVSA-T is (ER)−/(Pgr)−. Prior to the experiments, a mycoplasma test was carried out on all cell lines and found to be negative. All cell lines were maintained in a continuous logarithmic culture in RPMI 1640 medium with Hepes and phenol red. The medium was supplemented with 10% FCS, penicillin 100 μg/ml and streptomycin 100 μg/ml. The cells were mildly trypsinized for passage and for use in the experiments. RPMI and FCS were obtained from Life technologies (Paisley, Scotland). SRB, DMSO, Penicillin and streptomycin were obtained from Sigma (St. Louis MO, USA), TCA and acetic acid from Baker BV (Deventer, NL) and PBS from NPBI BV Table 2 Selected bond lengths (Å) and angles (°) for compounds (1 and 3) 1 3
Primed atoms refer to atoms from the next symmetrically-related ligand in the polymeric chain (symmetry code for 1: (Emmer-Compascuum, NL). The test compounds 1-4 and reference compounds were dissolved to a concentration of 250,000 ng/ml in full medium, by 20 fold dilution of a stock solution which contained 1 mg of compounds 1-4/ 200 μl. All the four compounds were dissolved in DMSO. Cytotoxicity was estimated by the microculture sulforhodamine B (SRB) test [65] .
The results of the in vitro cytotoxicity tests performed with triphenyltin(IV) compounds, (1-3) and diphenyltin (IV) compound (4) are summarized in Table 4 where the ligand is a Schiff base derived from phenylalanine [49] . There are also reports on di-n-butyltin(IV) and diphenyltin(IV) compounds with Schiff bases derived from glycine, β-alanine, and l-leucine and these were also investigated for in vitro cytotoxic potential (see Table 4 for details) [66] . The di-n-butyltin(IV) compounds of cognate systems were also investigated for antitumour activity against the NCI panel of 60 cell lines [67] . The results indicated that three of the di-n-butyltin (IV) 631L (renal cancer). In general, a low to moderate cellular response was observed for all the di-n-butyltin(IV) compounds, with at least one cell line in each subpanel of cells exhibiting a very low growth inhibition response. The results also indicated that the compounds did not exhibit any significant subpanel activity and suggested that the di-n-butyltin(IV) compounds were not active in all the cell lines contained in any subpanel. The di-n-butyltin(IV) compound of composition {[ n Bu 2 Sn(2-OHC 6 H 4 C(CH 3 )=N (CH 2 ) 2 COO)] 2 O} 2 (Table 4 ) also exhibited good activity especially when compared with CCDP [47] . Another interesting mixed organotin(IV) binuclear compound Ph 3 Sn (HL).Ph 2 SnL (L=2-O-3,5-Br 2 C 6 H 2 C(H)=NCHCH (CH 3 ) 2 COO) also displayed good in vitro cytotoxicity against three human tumour cell lines, i.e. HeLa (cervix tumour cell), CoLo 205 (colon carcinoma cell) and MCF-7 (mammary tumour cell) when compared with CCDP [68, 69] .
The triphenyltin(IV) compounds of the present investigation (1-3, Table 4 ) showed ID 50 values in the range 33-96, 42-104 and 31-38 ng/ml, respectively, whereas diphenyltin(IV) compound 4 produced an ID 50 value in the range 199-987 ng/ml, across seven human tumour cell lines. Triphenyltin(IV) compound 3 is the most promising candidate in this study and the most cytotoxic organotin (IV) complex so far with a Schiff base bearing amino acetate skeleton. Compound 3 is around 25 fold more active in magnitude in terms of the ID 50 value at least against the A498 and H226 cell lines and is found to be almost as cytotoxic as MTX and found to be much better particularly for the H226 cell line. Under identical conditions, compound 3 is far superior to CCDP across a panel of cell lines and the activity is more pronounced for the A498 (57 fold) and H226 (86 fold) cell lines. The increase in the cytotoxicity of triphenyltin(IV) compounds 1-3 across the cell lines is likely to be because of the noninvolvement of the nitrogen atom in the complexation with the tin atom (see Scheme 2 and Fig. 2 ), which allows easy dissociation of the complex so that it can subsequently bind to DNA. This corroborates the fact that diorganotin(IV) complexes show lower activity when the nitrogen atom coordinates to the tin atom [67] . A typical mode of bonding of diorganotin(IV) complexes is shown in Scheme 2 taking complex 4 as an example. However, the variations in in vitro cytotoxicity of the triphenyltin(IV) complexes may be due to different kinetic and mechanistic behaviour [49] . Conversely, the possibility of organotin compounds interacting with DNA at the level of the phosphate groups cannot be completely ruled out [70] . In conclusion, the present study describes new structures with improved in vitro anti-tumour activity, which is of added value in determining the structure activity relationship in the area of organotin(IV) chemistry with possible future clinical application.
Conclusions and outlook
The manuscript reports the preparation and crystal structures of some novel triphenyltin(IV) complexes which may find applications in cancer chemotherapy. The most promising triphenyltin(IV) compound 3 shows the highest cytotoxicity so far among the organotin(IV) compounds containing Schiff base amino acetate systems when tested in vitro across seven human tumour cell lines, indicating its high potential as an anti-cancer drug. It is intended to employ these compounds for testing in animal models and additionally to search for differently substituted Schiff base amino acetate skeletons in order to improve the solubility. Further work in this area is underway.
